Indonesia is home to 260 million people and is one of the fastest-growing pharmaceutical markets in Asia. Indonesia’s pharmaceutical market is ranked as the largest market in the ASEAN regions. According to Frost and Sullivan, Indonesia’s healthcare expenditure is projected to reach USD 60.6 billion in 2018 with a growth rate of 14.9%. Universal health coverage was introduced in 2014 with the Jaminan Kesehatan Nasional (JKN), which now includes 76% of the population, the largest single-payer scheme in the world. Indonesia needs to always increase the quality of healthcare for its citizen, aligns with the development of infrastructure and technology.
Image : 99insight.com